Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Sutro Biopharma (STRO) Non Operating Income (2017 - 2025)

Sutro Biopharma's Non Operating Income history spans 4 years, with the latest figure at -$8.4 million for Q3 2025.

  • For Q3 2025, Non Operating Income fell 143.9% year-over-year to -$8.4 million; the TTM value through Sep 2025 reached -$28.8 million, down 249.79%, while the annual FY2024 figure was $13.4 million, 1872.67% up from the prior year.
  • Non Operating Income for Q3 2025 was -$8.4 million at Sutro Biopharma, down from -$8.2 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $19.1 million in Q3 2024 and bottomed at -$8.4 million in Q3 2025.